학술논문
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial
Document Type
Article
Author
Clamp, A.R.; James, E.C.; Popoola, B.; Schiavone, F.; Badrock, J.; Fananapazir, F.; Cook, A.D.; Parmar, M.; Kaplan, R.; McNeish, I.A.; Dean, A.; Kim, J.-W.; O'Donnell, D.M.; Gallardo-Rincon, D.; Blagden, S.; Brenton, J.; Perren, T.J.; Sundar, S.; Lord, R.; Dark, G.; Hall, M.; Banerjee, S.; Glasspool, R.M.; Hanna, C.L.; Williams, S.; Scatchard, K.M.; Nam, H.; Essapen, S.; Parkinson, C.; McAvan, L.; Swart, A.M.; Ledermann, J.A.
Source
In: The Lancet Oncology . (The Lancet Oncology, July 2022, 23(7):919-930)
Subject
Language
English
ISSN
14745488
14702045
14702045